UPC CFI 400/2024
8. Juli 2024·EP4201327 Einheitspatent · FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH
Hauptaktenzeichen: ACT 40442/2024
- Verfahrensdetails
- StatusCase ClosedVerfahrensartEinstweilige VerfügungKategorieEinstweilige Maßnahmen
- Parteien
- Division
- Milan LD
- Technologie
- InstrumentsMedical technology
- Sprache
- English
- Erste Entscheidung
- 4. Sept. 2024
- Letzte Entscheidung
- 22. Nov. 2024
- EPA-Einspruch
- EOFlow Co., Ltd.Zurückgenommen2025-03-18
- KELLER SCHNEIDER PATENTANWALTS GMBHZulässig2025-03-19
- Inspicos P/SZurückgenommen2025-03-19
| Einstweilige Verfügung erlassen | Median Tage bis zur ersten Entscheidung | |
|---|---|---|
| Gesamt-UPC | 54% (38/70) | 124 |
| Milan LD | Gesperrt | Gesperrt |
| Richter Pierluigi Perrotti | Gesperrt | Gesperrt |
| Richter Alima Zana | Gesperrt | Gesperrt |
| Richter Anna-Lena Klein | Gesperrt | Gesperrt |
| Richter Uwe Schwengelbeck | Gesperrt | Gesperrt |
Vor dem UPC: Insulet Corporation (25 Verfahren)·A. Menarini Diagnostics s.r.l. (16 Verfahren)
Dieser Streit umfasst 5 weitere Verfahren
UPC APP 67784/2024·UPC CFI 793/2024·UPC CoA 769/2024·UPC APP 58035/2024·UPC APP 40442/2024
11 weitere Beklagte zum selben oder einem verwandten Patent
UPC CFI 1230/2026·UPC CoA 34/2026·UPC CoA 930/2025·UPC CFI 773/2025·UPC CoA 194/2025 und 6 weitere
Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.
- 2024-11-22Application for provisional measuresÖffentlich
Zusammenfassung: The Milan Local Division dismissed Insulet Corporation's application for provisional measures against A. Menarini Diagnostics S.r.l. concerning EP4201327 (insulin pump technology), finding the application inadmissible as the auxiliary requests to amend the patent are not permissible in provisional measures proceedings, and also dismissing Menarini's request for security for costs.
Rechtsfragen anzeigen (5)
- Provisional measures (R.206, R.209.1 RoP)
- Inadmissibility of patent amendment requests in PI proceedings (R.30.2 RoP)
- Amendment of case in PI proceedings (R.263.2-3 RoP)
- Requirements for provisional measures (R.211.2-3 RoP)
- Security for costs (Art. 69(4) UPCA, R.158 RoP)
- 2024-10-01Application for provisional measuresÖffentlich
Zusammenfassung: The Milan Local Division denied EOFLOW CO LTD's application to intervene as a third party in Insulet's provisional measures proceedings against Menarini under R.313 RoP, holding that efficiency of the proceedings and other balancing considerations weighed against admitting the intervention.
Rechtsfragen anzeigen (2)
- intervention R.313 RoP
- legal interest of manufacturer/producer to intervene in distributor proceedings
| Dokumenttitel | Datum | Öffentlich |
|---|---|---|
| Order | 2025-10-31 | Öffentlich |
| Order | 2025-10-31 | Öffentlich |
| Order | 2025-10-31 | Öffentlich |
| Order | 2025-10-31 | Öffentlich |
| Receipt | 2024-12-30 | Nicht öffentlich |
| Receipt | 2024-12-30 | Nicht öffentlich |
| Application | 2024-12-27 | Nicht öffentlich |
| Application | 2024-12-27 | Nicht öffentlich |
| Exhibit BB 56 | 2024-12-27 | Nicht öffentlich |
| Exhibit BB 52 | 2024-12-27 | Nicht öffentlich |
Insulet Corporation applied for provisional measures against A. Menarini Diagnostics before the Milan Local Division for alleged infringement of EP 4 201 327 (insulin pump technology). The court dismissed the application as inadmissible because Insulet sought to amend the patent via auxiliary requests, which are not permissible in provisional measures proceedings and can only be pursued in main proceedings; Menarini's request for EUR 200,000 security for costs was also rejected for lack of evidence of Insulet's insolvency risk.
Auxiliary requests to amend the patent under R. 30.2 RoP are inadmissible in provisional measures proceedings
BeklagterRechtsgrundlage: R. 30.2 RoP; R. 50.2 RoP; R. 263.2 RoPHinweis: Court agreed with Menarini that patent amendments under R. 30.2 RoP can only be lodged in main proceedings before the court with jurisdiction to issue a final validity decision.
Security for costs is not granted merely because the applicant is a US company, absent specific evidence of insolvency risk or insufficient assets
KlägerRechtsgrundlage: Art. 69.4 UPCA; R. 158 RoPHinweis: Court rejected Menarini's security-for-costs request, finding no substantiated allegation of alarming financial situation on Insulet's part.
Application for provisional measures for infringement of EP 4 201 327 relating to insulin pump technology
KlägerRechtsgrundlage: R. 211.2 RoP; R. 211.3 RoP; R. 30.2 RoPBegründung: Application was dismissed as inadmissible because Insulet sought to rely on auxiliary requests to amend the patent, which are not permissible in provisional measures proceedings; absence of one required condition (valid main request scope) is sufficient for dismissal.
Security for costs in the amount of EUR 200,000 due to risk of inability to enforce cost judgment against a US company
BeklagterRechtsgrundlage: Art. 69.4 UPCA; R. 158 RoPBegründung: Menarini failed to allege or prove circumstances indicating alarming financial situation; security for costs is not primarily intended to protect against difficulties of enforcing abroad.
Weitere Fälle zu diesem Grundsatz ansehen.
- US 994Erfindungsmüh-Kombination
The proceeding concerned EP 4 201 327 relating to a fluid delivery device with transcutaneous access tool (insulin pump). The court did not reach substantive claim construction because the application was dismissed on procedural grounds relating to the inadmissibility of patent amendment requests in provisional measures proceedings.